JAMES T KURNICK, M.D.
Medical Practice at Cummings Ctr, Beverly Farms, MA
License number
Massachusetts 45647
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
2
100 Cummings Ctr SUITE 430C, Beverly Farms, MA 01915
142 Highland Ave, Winchester, MA 01890
142 Highland Ave, Winchester, MA 01890
Phone
(978) 232-1243
Personal information
See more information about JAMES T KURNICK at radaris.comName
Address
Phone
142 Highland Ave, Winchester, MA 01890
18 Benmor St, Medford, MA 02155
1 Hilltop Rd, Ipswich, MA 01938
1 Hilltop Rd, Ipswich, MA 01938
29 Kings Way, Ipswich, MA 01938
Professional information
James T Kurnick, Beverly MA
Specialties:
Pathologist
Address:
100 Cummings Ctr, Beverly, MA 01915
Methods For Up-Regualting Antigen Expression Of Tumors
US Patent:
2004025, Dec 16, 2004
Filed:
Aug 29, 2003
Appl. No.:
10/651616
Inventors:
Paul Durda - Needham MA, US
James Kurnick - Winchester MA, US
Ian Dunn - Sydney, AU
James Kurnick - Winchester MA, US
Ian Dunn - Sydney, AU
International Classification:
A61K039/395
US Classification:
424/143100
Abstract:
The invention provides methods of modulating tumor antigen associated (TAA) expression, and methods of modulating TAA expression in order to treat a tumor. More particularly, the invention provides methods of increasing an immune response against a tumor cell. Methods include administering to a subject with a tumor an amount of IFN- receptor agonist and tumor associated antigen (TAA) sufficient to increase an immune response against the tumor cell.
Outer Membrane Protein A, Peptidoglycan-Associated Lipoprotein, And Murein Lipoprotein As Therapeutic Targets For Treatment Of Sepsis
US Patent:
2003001, Jan 23, 2003
Filed:
Mar 13, 2002
Appl. No.:
10/097538
Inventors:
H. Warren - Charlestown MA, US
Judith Hellman - Brookline MA, US
James Kurnick - Winchester MA, US
Judith Hellman - Brookline MA, US
James Kurnick - Winchester MA, US
International Classification:
A61K039/40, A61K039/02
US Classification:
424/164100, 424/190100
Abstract:
The present invention relates to three outer membrane proteins conserved among Gram-negative bacteria, OmpA, PAL, and MLP. The invention provides vaccines and polypeptides useful for passive and active immunization against Gram-negative bacteria, as well as methods of preventing and treating Gram-negative sepsis.